Cyclotides as novel plant-derived scaffolds for orally active cyclic peptide therapeutics.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Cyclotides as novel plant-derived scaffolds for orally active cyclic peptide therapeutics.
- Published In:
- Molecules and cells, 48(9), 100252 (2025)
- Authors:
- Hyun, Youbong
- Database ID:
- RPEP-11493
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11493APA
Hyun, Youbong. (2025). Cyclotides as novel plant-derived scaffolds for orally active cyclic peptide therapeutics.. Molecules and cells, 48(9), 100252. https://doi.org/10.1016/j.mocell.2025.100252
MLA
Hyun, Youbong. "Cyclotides as novel plant-derived scaffolds for orally active cyclic peptide therapeutics.." Molecules and cells, 2025. https://doi.org/10.1016/j.mocell.2025.100252
RethinkPeptides
RethinkPeptides Research Database. "Cyclotides as novel plant-derived scaffolds for orally activ..." RPEP-11493. Retrieved from https://rethinkpeptides.com/research/hyun-2025-cyclotides-as-novel-plantderived
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.